Adare Pharma Solutions
Adare Pharma Solutions is a global contract development and manufacturing organization (CDMO) that specializes in advanced pharmaceutical technologies. The company offers a comprehensive suite of services, including product development, commercial manufacturing, formulation development, analytical services, clinical trials, and packaging. With a focus on proprietary oral drug-delivery platforms, Adare provides innovative solutions such as taste masking, controlled release, solubility enhancement, and patient-centric dosing. These technologies aim to facilitate the commercialization of safe and effective pharmaceutical products, assisting biopharmaceutical companies in developing novel and enhanced medicines for the global market.
Orbis Biosciences, Inc. specializes in developing controlled-release delivery systems applicable across various sectors, including pharmaceuticals, consumer products, chemicals, and food and beverage industries. Established in 2007 and based in Lenexa, Kansas, the company utilizes precision particle fabrication technology to allow businesses to innovate and enhance their product offerings by controlling critical particle parameters such as size, encapsulation material, shell thickness, and porosity. This scalability enables Orbis Biosciences to provide tailored solutions for a diverse range of applications, from drug formulations to agricultural compounds and novel food processing techniques. The company's technologies focus on creating uniform microspheres and microcapsules, optimizing both oral and injectable pharmaceutical products through customized drug release and format flexibility, ultimately improving compliance for end users. As of April 30, 2020, Orbis operates as a subsidiary of Adare Pharmaceuticals, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.